Skip to content

Predictive Value Of Admission Blood Glucose Level In Patients With Acute Myocardial Infarction

Predictive ValueOf Admission Blood Glucose Level In Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Angioplasty

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03164707
Enrollment
100
Registered
2017-05-24
Start date
2017-12-01
Completion date
2019-06-01
Last updated
2017-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Predictive Value of Admission Blood Glucose Level in Acute Myocardial Infarction

Brief summary

Coronary atherosclerosis is the leading cause of death worldwide. Diabetes mellitus is associated with increased prevalence of coronary artery disease Increased plasma glucose is a common feature in the acute phase of myocardial infarction, even in patients without diabetes. Patients with stress hyperglycemia, but without previous diagnosis of diabetes, were at increased risk of congestive heart failure, arrhythmia and cardiogenic shock as well as increased both in-hospital and long-term mortality . Previous studies have demonstrated larger infarct size and poorer prognosis inpatients with hyperglycemia upon hospital admission compared with patients without hyperglycemia It has been reported that stress hyperglycemia impairs microvascular circulation and may lead to no-reflow phenomenon. No reflow phenomenon was significantly more frequent among patients with hyperglycemia and increased progressively with increasing admission blood glucose in patients with Acute Myocardial Infarction . Furthermore, patients with high admission glucose are more likely to develop restenosis and require repeat revascularization procedures compared with those with normal admission glucose and are also at increased risk for repeated Myocardial Infarction, stent thrombosis and death.

Interventions

DIAGNOSTIC_TESTBlood Glucose Level

ON Admission Blood Glucose Level Fasting Blood Glucose Level

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

acute ST Segment Elevation Myocardial Infarction patients not known to have Diabetes Mellitus undergoing primary PCI.

Exclusion criteria

* patients known to have Diabetes mellitus (known diabetes mellitus on admission, which was treated with diet, oral glucose-lowering medication, and/or insulin). * Patients with prior Primary Percutaneous Intervention and/or Coronary Artery Bypass Graft (altering disease state). * Patients with severe liver or renal disease (altering disease state). * Patients with anemia, kidney disease or certain blood disorders (thalassemia).

Design outcomes

Primary

MeasureTime frame
Correlation of level of blood glucose on admission in patients with ST Segment Elevation Myocardial Infarction and Hospital Outcome1 month

Contacts

Primary ContactAmr Ahmed Yousef, Professor
Amryoussef111@yahoo.com01006554042
Backup ContactHeba Mahmoud Elnaggar, Lecturer
Heba_m_elnaggar@yahoo.com01001963100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026